03.03.2014 Views

European Society of Mycobacteriology - Instituto Nacional de Saúde ...

European Society of Mycobacteriology - Instituto Nacional de Saúde ...

European Society of Mycobacteriology - Instituto Nacional de Saúde ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

PP-73<br />

QUANTIFERON ® -TB GOLD IN-TUBE TEST USED IN PRAGUE<br />

PATIENTS LISTED IN THE NATIONAL TUBERCULOSIS REGISTER<br />

Havelkova, Marta 1 , Bartu, Vaclava 2 , Kubin, Milan 3<br />

1 - National Institute <strong>of</strong> Public Health – NRL for mycobacteria<br />

2 - Charles University , Faculty <strong>of</strong> Medicine, Faculty Thomayer Hospital<br />

3 - Prague Hygiene Institute<br />

In 2006-2007, 65 (29.0%) <strong>of</strong> 224 patients registered in the A15, A16 and A18/19 categories (58.5%, 32.3% and 9.2% <strong>of</strong> all<br />

patients, respectively) were assessed using both the QuantiFERON – TB Gold In-Tube (QFT) method and the tuberculin<br />

skin test (TST) with 2 TU PPD.<br />

After stimulation with tuberculosis-specific antigens, a low level <strong>of</strong> interferon-gamma (IFG) production (< 0.35 IU) was<br />

found in 18 (27.7%) patients and mo<strong>de</strong>rate or high levels (> 0.35 IU) in the remaining 47 (72.3%) patients. After incubation<br />

with a non-specific mitogen, a low level <strong>of</strong> IFG production was recovered in 13 (20%) individuals, with mo<strong>de</strong>rate or<br />

high levels being found in the remaining 52 (80%) patients.<br />

The TST revealed low levels <strong>of</strong> skin infiltrate reaction (0-5 mm) in 25 patients (39.1%) and mo<strong>de</strong>rate or high levels <strong>of</strong> skin<br />

reaction (range 6 - > 30 mm) in the remaining 39 individuals (60.9%).<br />

The high proportion <strong>of</strong> low reagent levels in both the QFT and tuberculin skin tests can be explained by a high number <strong>of</strong><br />

ol<strong>de</strong>r patients, comorbidity with malignant tumours, diabetes or general fatigue in pre-terminal patients, and the immune<br />

systém insufficiency related to these factors.<br />

^<br />

This presentation was fully supported by project KAN 200520702 <strong>of</strong> the Grant Agency <strong>of</strong> Czech Aca<strong>de</strong>my <strong>of</strong> Sciences (GAAV CqR).<br />

<strong>European</strong> <strong>Society</strong> <strong>of</strong> <strong>Mycobacteriology</strong> | 30 th Annual Congress | July 2009 | Porto - Portugal<br />

145

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!